| Serial Number | 97261958 |
| Word Mark | BIOTRILLION |
| Filing Date | Thursday, February 10, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, April 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 5, 2023 |
| Goods and Services | downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data |
| Goods and Services | Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug use |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 15, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 15, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BioTrillion, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francsico, CA 94105 |
| Party Name | BioTrillion, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francsico, CA 94105 |
| Event Date | Event Description |
| Monday, February 14, 2022 | NEW APPLICATION ENTERED |
| Tuesday, February 15, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 23, 2022 | ASSIGNED TO EXAMINER |
| Monday, December 5, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, December 5, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, December 5, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 6, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, April 6, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, April 6, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 29, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 31, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 15, 2024 | SOU EXTENSION 1 FILED |
| Monday, April 15, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | TEAS STATEMENT OF USE RECEIVED |